Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 401-410 of 538 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Study to Evaluate the Use of Organoids to Advance Precision Medicine in Bladder Cancer

    Rochester, MN

  2. Open Nipple Sparing Mastectomy (NSM)

    Rochester, MN

  3. Mindfulness-Based Intervention (Muse-S™) as an Adjunct During Diagnostic Work-up in Patients Presenting to the Undiagnosed Mass Clinic (UMC).

    Scottsdale/Phoenix, AZ, Rochester, MN

  4. Tools to evaluate treatment tolerability in older patients with sarcoma

    Rochester, MN

  5. A Study of Prostate Cancer Care and Survivorship Among Sub-Saharan African Immigrant Impacted by Social Determinants of Migrant Health Factors

    Rochester, MN

  6. A Study to Evaluate the Immune Response to Anti-HER2 Therapies

    Jacksonville, FL

  7. Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events

    Jacksonville, FL

  8. Evaluation of Outcomes in Metastatic Gastric and Esophageal Carcinoma in Relation to Immunotherapy

    Rochester, MN

  9. International Hepatobiliary Neoplasia Registry and Biorepository

    Scottsdale/Phoenix, AZ, Rochester, MN, Jacksonville, FL

  10. MElanoma Research Lymph node prediction Implementation National_001 (MERLIN_001)

    Rochester, MN

.

Mayo Clinic Footer